Simplex Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-31
| Closed | -$15K | – | 8322 |
|
|
2019
Q2 | $15K | Hold |
31
| – | – | ﹤0.01% | 5867 |
|
|
2019
Q1 | $11K | Buy |
+31
| New | +$134 | ﹤0.01% | 6133 |
|
|
2018
Q4 | – | Sell |
-71
| Closed | -$41K | – | 8327 |
|
|
2018
Q3 | $41K | Buy |
71
+9
| +15% | +$45 | ﹤0.01% | 5365 |
|
|
2018
Q2 | $26K | Buy |
+62
| New | +$313 | ﹤0.01% | 5671 |
|
|
2017
Q3 | – | Sell |
-151
| Closed | -$8K | – | 7072 |
|
|
2017
Q2 | $8K | Buy |
151
+60
| +66% | +$369 | ﹤0.01% | 4237 |
|
|
2017
Q1 | $3K | Buy |
+91
| New | +$614 | ﹤0.01% | 5149 |
|
|
2016
Q4 | – | Sell |
-9
| Closed | -$5K | – | 6903 |
|
|
2016
Q3 | $5K | Sell |
9
-136
| -94% | -$1.13K | ﹤0.01% | 4367 |
|
|
2016
Q2 | $1K | Buy |
145
+83
| +134% | +$534 | ﹤0.01% | 5581 |
|
|
2016
Q1 | $2K | Buy |
62
+52
| +520% | +$196 | ﹤0.01% | 4899 |
|
|
2015
Q4 | $1K | Sell |
10
-1
| -9% | -$7 | ﹤0.01% | 5143 |
|
|
2015
Q3 | $2K | Buy |
11
+1
| +10% | +$17 | ﹤0.01% | 4819 |
|
|
2015
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 4449 |
|
|
2015
Q1 | $3K | Sell |
10
-5
| -33% | -$89 | ﹤0.01% | 3969 |
|
|
2014
Q4 | $10K | Buy |
+15
| New | +$187 | ﹤0.01% | 2612 |
|
Other funds holding PETX
Simplex Trading's PETX Position: Q3 2019 in Review
Simplex Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,159 shares — an estimated $52K sold.
Simplex Trading first reported a position in PETX in Q1 2015 and held it in 11 quarters. The position peaked at $84K in Q1 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Simplex Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 10,159 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
- Simplex Trading first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
- Simplex Trading's Aratana Therapeutics, Inc. position peaked at $84K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.